Missed targets are bad, but imagine if they hadn't switched gears on products once they ran into significant road block(s) on the gallium arsenide? When one talks about delays and missed targets it must be taken into account that they totally switched gears. The long investors here have been willing to wait in order to see this be developed even though it has taken much longer than we anticipated, and it was probably a much riskier course to take.  Many of us did not want a quick buyout, but rather wanted them to keep the technology and develop it. I wanted and still want, to see if this story plays out to be the game changer I hope that it is. This has meant a much longer road and hopefully a very rewarding long term investment.  I hope we are nearing a time when we are on more solid financial footing, revenue producing, and multi-product generating company (disruptive and or in a pole position). Remember when SI sold? Evidently he didn't want to wait it out. How many of us would be re-entering Poet at this time had we sold back when?  Chances are that many of those folks have long since forgotten about Poet. Time will tell if we will be rewarded for our patience and loyalty.  Hopefully soon. (I know, that word stings). And yes, I worry about another financing, but I am more hopeful that significant revenue is around the corner, precluding the need for another one. Who is still here?  Sadly, there are some whose time ran out. Good luck to all longs.  Let's get some revenue Poet!